We are live on
!
Find out more
Mirae Asset Global Investments Portfolio holdings
AUM
$67.7B
1-Year Est. Return
57.61%
This Fund
S&P 500
This Quarter
Est. Return
+4.39%
1 Year Est. Return
+57.61%
3 Year Est. Return
+150.9%
5 Year Est. Return
+201.56%
10 Year Est. Return
+1,018.7%
AUM
$36B
AUM Growth
+$4.16B
(+13%)
Cap. Flow
+$3.25B
Cap. Flow
% of AUM
9.02%
Top 10 Holdings %
Top 10 Hldgs %
37.04%
Holding
1,767
New
125
Increased
1,085
Reduced
387
Closed
124
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$315M |
| 2 |
Apple
AAPL
|
+$187M |
| 3 |
Microsoft
MSFT
|
+$171M |
| 4 |
Meta Platforms (Facebook)
META
|
+$118M |
| 5 |
Tesla
TSLA
|
+$116M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$61.1M |
| 2 |
PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund
ZROZ
|
+$51.8M |
| 3 |
Invesco Aerospace & Defense ETF
PPA
|
+$38.3M |
| 4 |
Schwab US Dividend Equity ETF
SCHD
|
+$37.5M |
| 5 |
Invesco S&P 500 Momentum ETF
SPMO
|
+$36M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.91% |
| 2 | Communication Services | 10.86% |
| 3 | Consumer Discretionary | 9.43% |
| 4 | Healthcare | 6.67% |
| 5 | Financials | 5.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALX
1576
Alexander's
ALX
$1.39B
| $14.8K | ﹤0.01% |
68
+18
| +36% | +$4.02K |
|
|
MENS
1577
Jyong Biotech
MENS
$151M
| $14.6K | ﹤0.01% |
+3,694
| New | +$130K |
|
1578
Puma Biotechnology
PBYI
$459M
| $14.6K | ﹤0.01% |
+2,449
| New | +$13K |
|
1579
Neumora Therapeutics
NMRA
$317M
| $14.5K | ﹤0.01% |
8,119
+1,858
| +30% | +$4.07K |
|
|
GOOD
1580
Gladstone Commercial Corp
GOOD
$630M
| $14.5K | ﹤0.01% |
1,361
+347
| +34% | +$3.86K |
|
1581
KVH Industries
KVHI
$142M
| $14.4K | ﹤0.01% |
2,073
| – | – |
|
|
AARD
1582
Aardvark Therapeutics
AARD
$144M
| $13.9K | ﹤0.01% |
+1,058
| New | +$13.2K |
|
|
SLN
1583
Silence Therapeutics
SLN
$641M
| $13.9K | ﹤0.01% |
2,282
+466
| +26% | +$2.98K |
|
1584
Boston Beer
SAM
$1.89B
| $13.9K | ﹤0.01% |
71
-3
| -4% | -$619 |
|
1585
Atea Pharmaceuticals
AVIR
$405M
| $13.6K | ﹤0.01% |
3,796
+728
| +24% | +$2.31K |
|
|
RAL
1586
Ralliant Corp
RAL
$8.03B
| $13.3K | ﹤0.01% |
261
+40
| +18% | +$1.88K |
|
|
LX
1587
LexinFintech Holdings
LX
$237M
| $13.2K | ﹤0.01% |
4,044
-1,774
| -30% | -$7.28K |
|
1588
Liberty Live Group Series C
LLYVK
$9.8B
| $13K | ﹤0.01% |
156
-4
| -3% | -$343 |
|
1589
OmniAb
OABI
$497M
| $12.9K | ﹤0.01% |
6,995
+2,251
| +47% | +$3.91K |
|
|
CTNM
1590
Contineum Therapeutics
CTNM
$564M
| $12.8K | ﹤0.01% |
+1,122
| New | +$12.8K |
|
|
BFS
1591
Saul Centers
BFS
$850M
| $12.3K | ﹤0.01% |
391
+99
| +34% | +$3.04K |
|
1592
Orchestra BioMed
OBIO
$266M
| $11.4K | ﹤0.01% |
+2,744
| New | +$11.1K |
|
1593
Marathon Digital Holdings
MARA
$3.72B
| $11.3K | ﹤0.01% |
1,261
+212
| +20% | +$3.13K |
|
1594
Voyager Therapeutics
VYGR
$197M
| $11.3K | ﹤0.01% |
2,864
+720
| +34% | +$3.19K |
|
1595
U-Haul Holding Co Series N
UHAL.B
$12.7B
| $10.9K | ﹤0.01% |
233
+23
| +11% | +$1.12K |
|
1596
nCino
NCNO
$2.08B
| $10.8K | ﹤0.01% |
422
+71
| +20% | +$1.8K |
|
1597
Vor Biopharma
VOR
$1.21B
| $10.7K | ﹤0.01% |
+819
| New | +$15.3K |
|
1598
Virtu Financial
VIRT
$5.04B
| $10.5K | ﹤0.01% |
316
+53
| +20% | +$1.81K |
|
1599
Quantum-Si Incorporated
QSI
$182M
| $10.5K | ﹤0.01% |
+9,503
| New | +$15.5K |
|
1600
Cabaletta Bio
CABA
$465M
| $10.2K | ﹤0.01% |
+4,678
| New | +$11.6K |
|
Similar funds
Mirae Asset Global Investments's Q4 2025 Portfolio in Review
As of Q4 2025, Mirae Asset Global Investments held 1,767 positions worth $36B, up 13% from $31.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Mirae Asset Global Investments deployed $3.25B of net new capital in Q4 2025, opening 125 new positions and adding to 1,085 existing holdings. Its largest new stake was iShares Biotechnology ETF: 195,308 shares worth $33M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 36% a quarter earlier, followed by Communication Services and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $61.1M trimmed.
- Mirae Asset Global Investments's largest Q4 2025 buy was iShares Biotechnology ETF: 195,308 shares worth $33M.
- Mirae Asset Global Investments added most to NVIDIA in Q4 2025, an estimated $315M increase.
- Mirae Asset Global Investments's biggest Q4 2025 reduction was Vanguard S&P 500 ETF, cutting an estimated $61.1M.
- Mirae Asset Global Investments fully exited Invesco Aerospace & Defense ETF in Q4 2025, selling an estimated $38.3M.
- Mirae Asset Global Investments's ten largest holdings make up 37% of its $36B portfolio in Q4 2025.
- Mirae Asset Global Investments opened 125 new positions and closed 124 in Q4 2025.
- Mirae Asset Global Investments's portfolio value rose 13% quarter-over-quarter to $36B.
Based on Mirae Asset Global Investments's 13F filing for Q4 2025, filed 26 Jan 2026.